Monografie
Determination of uPA and PAI-1 by ELISA in small amounts of breast cancer tissue : clinical evaluation in pre- and post-primary systemic therapy specimens
- Sprache
-
Englisch
- Anmerkungen
-
München, Techn. Univ., Diss., 2008
- Identifier
-
989320677
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:56 MEZ
Objekttyp
- Monografie
Ähnliche Objekte (12)
Novel DNA-methylation response marker vitronectin : assessment in tissue specimens of normal and cancerous breast tissue by immunohistochemistry
Exercise for women receiving adjuvant therapy of breast-cancer : a systematic review
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Evaluation of side effects after axillary lymph node dissection for breast cancer taking tumour staging status into account
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
The impact of human adipose tissue-derived stem cells on breast cancer cells : implications for cell-assisted lipotransfers in breast reconstruction
Clinical usefulness of cancer markers in primary breast cancer
Effect of genetic kinome alterations on the response of cancer cells to SUTENT therapy
Tissue microarray based identification of molecular cancer therapy targets in clinical routine
Clinical relevance of the tissue protease KLK4 for triple-negative breast cancer
STAT3 inhibitors for cancer treatment
Structural and biochemical characterization of proteins involved in cancer
Novel DNA-methylation response marker vitronectin : assessment in tissue specimens of normal and cancerous breast tissue by immunohistochemistry
Exercise for women receiving adjuvant therapy of breast-cancer : a systematic review
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Evaluation of side effects after axillary lymph node dissection for breast cancer taking tumour staging status into account
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
The impact of human adipose tissue-derived stem cells on breast cancer cells : implications for cell-assisted lipotransfers in breast reconstruction
Clinical usefulness of cancer markers in primary breast cancer
Effect of genetic kinome alterations on the response of cancer cells to SUTENT therapy
Tissue microarray based identification of molecular cancer therapy targets in clinical routine
Clinical relevance of the tissue protease KLK4 for triple-negative breast cancer
STAT3 inhibitors for cancer treatment
Structural and biochemical characterization of proteins involved in cancer
Novel DNA-methylation response marker vitronectin : assessment in tissue specimens of normal and cancerous breast tissue by immunohistochemistry
Exercise for women receiving adjuvant therapy of breast-cancer : a systematic review
Quantification of urokinase plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) mRNA in breast cancer tissue
Evaluation of side effects after axillary lymph node dissection for breast cancer taking tumour staging status into account
The role of tumour suppressor tyrosine kinase SYK in glioblastoma and breast cancer
The impact of human adipose tissue-derived stem cells on breast cancer cells : implications for cell-assisted lipotransfers in breast reconstruction
Clinical usefulness of cancer markers in primary breast cancer
Effect of genetic kinome alterations on the response of cancer cells to SUTENT therapy
Tissue microarray based identification of molecular cancer therapy targets in clinical routine
Clinical relevance of the tissue protease KLK4 for triple-negative breast cancer
STAT3 inhibitors for cancer treatment